HUM Humana Inc. Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Lip 29, 2026HUM Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
HUM Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 1 sierpnia 1991 | 3-for-2 | Naprzód |
| 1 lutego 1984 | 6-for-5 | Naprzód |
| 1 lutego 1983 | 4-for-3 | Naprzód |
| 1 lutego 1982 | 3-for-2 | Naprzód |
O Humana Inc. Common Stock Przegląd firmy z Wikipedii
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value.
In 2010, Humana returned to providing healthcare services when it bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million. They went on to sell Concentra again in 2015 for $1 billion.
In July 2015, Aetna announced that it would acquire Humana for $37 billion. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna and Humana cancelled a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO.
In 2024 Humana announced that they would be leaving the Humana Building, which they had occupied since the 1980s, in order to cut costs. Humana said that it planned to consolidate its workforce in its Waterside-Clocktower campus.
In 2026 KFF reported that Humana was the second-largest parent organization for Medicare Advantage by overall enrollment, and that it had the largest growth in that sector that year.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
In 2009, HMHS' contract with the military was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | HUM | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 36.7średnia z 5 lat ≈23.6 | ≈23.6 | 36.3 | Zawyżona wycena | |
| P/S (TTM) | 0.5średnia z 5 lat ≈0.7 | ≈0.7 | 0.7 | Niedowartościowany | |
| P/B (MRQ) | 4.0średnia z 5 lat ≈4.6 | ≈4.6 | 3.9 | Wartość godziwa | |
| EV / EBITDA | 25.8średnia z 5 lat ≈19.0 | ≈19.0 | 16.1 | Wartość godziwa | |
| Cena / FCF (TTM) | 39.6średnia z 5 lat ≈54.2 | ≈54.2 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 30.4średnia z 5 lat ≈29.3 | ≈29.3 | 15.6 | Zawyżona wycena | |
| EV / Przychody (TTM) | 0.4średnia z 5 lat ≈0.6 | ≈0.6 | · | · | |
| EV / FCF (TTM) | 33.5średnia z 5 lat ≈46.5 | ≈46.5 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 4.3średnia z 5 lat ≈14.5 | ≈14.5 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | HUM | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | 1.9%średnia z 5 lat ≈3.2% | ≈3.2% | 3.5% | Słaby | |
| EBITDA Margin (Marża EBITDA) | 2.1%średnia z 5 lat ≈3.2% | ≈3.2% | 3.7% | Słaby | |
| Marża przed opodatkowaniem (TTM) | 1.1%średnia z 5 lat ≈2.7% | ≈2.7% | 2.8% | Słaby | |
| Marża Zysku Netto (TTM) | 0.88%średnia z 5 lat ≈2.2% | ≈2.2% | 2.9% | Słaby | |
| ROA (TTM) | 2.4%średnia z 5 lat ≈4.9% | ≈4.9% | 3.0% | Słaby | |
| ROE (TTM) | 6.8%średnia z 5 lat ≈13.3% | ≈13.3% | 10.1% | Słaby | |
| ROIC | 7.4%średnia z 5 lat ≈9.7% | ≈9.7% | 8.0% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | HUM | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.6średnia z 5 lat ≈0.7 | ≈0.7 | 0.7 | Niski dług | |
| Wskaźnik bieżący (MRQ) | 1.7średnia z 5 lat ≈1.7 | ≈1.7 | 1.7 | Silna płynność | |
| Wskaźnik Szybkości (MRQ) | 1.3średnia z 5 lat ≈1.3 | ≈1.3 | 1.3 | Zgodnie z | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.6średnia z 5 lat ≈0.7 | ≈0.7 | 0.7 | Niski dług |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | HUM | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 10.1%średnia z 5 lat ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 11.8%średnia z 5 lat ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 10.9% | · | · | · | |
| EPS YoY | -1.4%średnia z 5 lat ≈-14.8% | ≈-14.8% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -1.6%średnia z 5 lat ≈-16.3% | ≈-16.3% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | -23.6%średnia z 5 lat ≈-18.4% | ≈-18.4% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | -17.2% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | -24.9%średnia z 5 lat ≈-20.0% | ≈-20.0% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | -18.8% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | HUM | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 2.7średnia z 5 lat ≈2.4 | ≈2.4 | 2.4 | Zgodnie z | |
| Receivables Turnover (Rotacja należności) | 43.4średnia z 5 lat ≈52.0 | ≈52.0 | 16.3 | Najwyższa półka | |
| Revenue / Employee (Przychody / pracownika) | ≈$1.9M | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Cze 26, 2026 | $0,89 | USD | ≈0.92% |
| Mar 27, 2026 | $0,89 | USD | ≈2.1% |
| Gru 26, 2025 | $0,89 | USD | ≈1.4% |
| Wrz 26, 2025 | $0,89 | USD | ≈1.4% |
| Cze 27, 2025 | $0,89 | USD | ≈1.5% |
| Mar 28, 2025 | $0,89 | USD | ≈1.3% |
| Gru 31, 2024 | $0,89 | USD | ≈1.4% |
| Wrz 30, 2024 | $0,89 | USD | ≈1.1% |
| Cze 28, 2024 | $0,89 | USD | ≈0.95% |
| Mar 27, 2024 | $0,89 | USD | ≈1.0% |
| Gru 28, 2023 | $0,89 | USD | ≈0.78% |
| Wrz 28, 2023 | $0,89 | USD | ≈0.70% |
| Cze 29, 2023 | $0,89 | USD | ≈0.75% |
| Mar 30, 2023 | $0,89 | USD | ≈0.67% |
| Gru 29, 2022 | $0,79 | USD | ≈0.61% |
| Wrz 29, 2022 | $0,79 | USD | ≈0.62% |
| Cze 29, 2022 | $0,79 | USD | ≈0.64% |
| Mar 30, 2022 | $0,79 | USD | ≈0.66% |
| Gru 30, 2021 | $0,70 | USD | ≈0.60% |
| Wrz 29, 2021 | $0,70 | USD | ≈0.69% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 29, 2026 | $7.61 | $7.29 | 4.3% |
| 31 marca 2026 | $10.31 | $10.29 | 0.21% | |
| 31 grudnia 2025 | $-3.96 | $-4.05 | 2.1% | |
| 30 września 2025 | $3.24 | $2.85 | 13.8% | |
| 30 czerwca 2025 | $6.27 | $5.98 | 4.9% | |
| 31 marca 2025 | $11.58 | $10.17 | 13.9% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $88.85 | $82.40 | $81.85 | $77.07 | · | · | · | · | · | · | · | · | |
| Revenue / Share | $1073.15 | $974.29 | $854.81 | $730.72 | $641.94 | $580.06 | $481.63 | $411.20 | $369.32 | $360.32 | $359.19 | $311.15 | |
| Cash Flow / Share | $7.62 | $24.54 | $31.99 | $36.09 | $17.48 | $42.39 | $39.22 | $15.70 | $27.83 | $12.83 | $5.74 | $10.38 | |
| Cash / Share | $21.14 | $11.18 | $23.62 | $25.47 | · | · | · | · | · | · | · | · | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | $1.16 | $1.15 | $1.11 | |
| Dividend Paid / Share | $3.54 | $3.54 | $3.44 | $3.06 | $2.73 | $2.43 | $2.15 | $1.90 | $1.49 | $1.16 | $1.14 | $1.10 | |
| EPS (TTM) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | · | 120,273,000 | 120,539,000 | 120,666,000 | · | 120,405,000 | 120,445,000 | 120,978,000 | · | 123,426,000 | 124,574,000 | 125,005,000 | · | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | · | 120,745,000 | 120,745,000 | 120,844,000 | · | 120,764,000 | 120,665,000 | 121,268,000 | · | 123,983,000 | 125,109,000 | 125,564,000 | · | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $96.68 | $93.50 | · | $93.21 | $91.76 | $89.33 | · | $88.39 | $83.89 | $81.18 | · | $85.30 | $84.72 | $83.44 | · | $82.13 | |
| Revenue / Share | $337.37 | $328.61 | · | $270.40 | $268.23 | $265.73 | · | $243.43 | $244.81 | $244.18 | · | $213.12 | $213.79 | $212.98 | · | $179.02 | |
| Cash Flow / Share | · | $10.39 | · | · | · | $2.74 | · | · | · | $3.49 | · | · | · | $53.26 | · | · | |
| Cash / Share | $34.69 | $24.91 | · | $27.11 | $20.33 | $21.39 | · | $25.74 | $27.68 | $29.74 | · | $76.24 | $81.60 | $69.14 | · | $68.24 | |
| Dividend / Share | $0.89 | $0.89 | $0.89 | · | · | $0.89 | $0.89 | · | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | · | · | · | · | · | · | |
| EPS (TTM) | $10.59 | $9.37 | · | $10.70 | $13.06 | $14.17 | · | $11.47 | $14.20 | $16.24 | · | $24.16 | $26.84 | $24.66 | · | $22.05 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.68B | $137.20B | · | $126.36B | $123.11B | $120.26B | · | $115.01B | $112.04B | $109.24B | · | $102.35B | $98.73B | $95.64B | · | $91.48B | |
| Net Income TTM | $1.28B | $1.13B | · | $1.29B | $1.58B | $1.71B | · | $1.36B | $1.71B | $1.99B | · | $3.02B | $3.38B | $3.12B | · | $2.81B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 37.5 | 18.5 | · | 24.3 | 18.7 | 18.7 | · | 27.6 | 26.3 | 21.3 | · | 20.1 | 16.7 | 19.7 | · | 22.0 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | |
| Dividend Yield | 0.54% | 1.2% | · | 0.83% | 0.88% | 0.82% | · | 0.69% | 0.59% | 0.64% | · | 0.44% | 0.46% | 0.42% | · | 0.40% | |
| Earnings Yield | 2.7% | 5.4% | · | 4.1% | 5.3% | 5.4% | · | 3.6% | 3.8% | 4.7% | · | 5.0% | 6.0% | 5.1% | · | 4.5% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · | |
| Annual Payout | $430M | $429M | · | $429M | $429M | $430M | · | $434M | $436M | $440M | · | $421M | $412M | $401M | · | $382M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Marża Operacyjna % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| Zysk netto | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| Rozwodniony EPS | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| Wskaźnik bieżący | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| Wskaźnik Szybkości | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $375M | $2.39B | $2.98B | $3.47B | $946M |
Właściciele instytucjonalni (13F) 1 038 emitentów · $52.7B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 248 (+126 vs poprzedni kw.) | 85 (-76 vs poprzedni kw.) | 325 (+68 vs poprzedni kw.) | 288 (-56 vs poprzedni kw.) | +3.9M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Dodge & Cox | $4 345 737 744 | 10 940 380 | 8,25% | Akcje |
| BlackRock, Inc. | $4 138 159 785 | 10 417 803 | 7,85% | Akcje |
| VANGUARD GROUP INC | $3 652 890 202 | 14 261 860 | 6,93% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 115 642 737 | 7 843 620 | 5,91% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 311 405 702 | 5 818 956 | 4,39% | Akcje |
| STATE STREET CORP | $2 172 441 313 | 5 457 072 | 4,12% | Akcje |
| PZENA INVESTMENT MANAGEMENT LLC | $1 749 013 682 | 4 403 136 | 3,32% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1 664 784 292 | 3 578 245 | 3,16% | Akcje |
| EAGLE CAPITAL MANAGEMENT LLC | $1 528 010 749 | 3 846 762 | 2,90% | Akcje |
| Sessa Capital IM, L.P. | $1 480 732 883 | 3 727 740 | 2,81% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $1 337 386 742 | 3 369 757 | 2,54% | Akcje |
| JPMORGAN CHASE & CO | $1 257 951 102 | 3 234 637 | 2,39% | Akcje |
| FMR LLC | $1 157 405 236 | 2 913 763 | 2,20% | Akcje |
| Capital International Investors | $950 462 637 | 2 392 826 | 1,80% | Akcje |
| GOLDMAN SACHS GROUP INC | $913 562 254 | 2 299 889 | 1,73% | Akcje |
| NAYA CAPITAL MANAGEMENT UK LTD | $728 407 339 | 1 833 763 | 1,38% | Akcje |
| NORGES BANK | $694 505 009 | 1 748 414 | 1,32% | Akcje |
| Invesco Ltd. | $587 403 999 | 1 478 788 | 1,11% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544 521 489 | 1 370 831 | 1,03% | Akcje |
| MORGAN STANLEY | $535 876 914 | 1 349 066 | 1,02% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $445 839 059 | 1 122 669 | 0,85% | Akcje |
| Capital Research Global Investors | $443 462 035 | 1 116 990 | 0,84% | Akcje |
| NORTHERN TRUST CORP | $442 978 948 | 1 115 198 | 0,84% | Akcje |
| Slate Path Capital LP | $428 969 795 | 1 079 930 | 0,81% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $423 436 520 | 1 066 000 | 0,80% | Opcja sprzedaży |
| Capital World Investors | $406 119 738 | 1 022 425 | 0,77% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $399 841 652 | 1 006 600 | 0,76% | Opcja kupna |
| Newport Trust Company, LLC | $384 768 345 | 968 653 | 0,73% | Akcje |
| CITADEL ADVISORS LLC | $363 376 856 | 914 800 | 0,69% | Opcja kupna |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348 908 912 | 878 377 | 0,66% | Akcje |
| Legal & General Group Plc | $329 760 125 | 830 170 | 0,63% | Akcje |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314 921 577 | 792 814 | 0,60% | Akcje |
| CITADEL ADVISORS LLC | $310 904 094 | 782 700 | 0,59% | Opcja sprzedaży |
| Allianz Asset Management GmbH | $307 098 329 | 773 119 | 0,58% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $304 014 312 | 765 355 | 0,58% | Akcje |
| BANK OF AMERICA CORP /DE/ | $279 490 113 | 703 615 | 0,53% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $267 791 027 | 674 163 | 0,51% | Akcje |
| Maple Rock Capital Partners Inc. | $249 553 862 | 628 251 | 0,47% | Akcje |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245 555 446 | 618 185 | 0,47% | Akcje |
| Bank of New York Mellon Corp | $238 144 113 | 599 527 | 0,45% | Akcje |
| GOLDMAN SACHS GROUP INC | $232 333 978 | 584 900 | 0,44% | Opcja kupna |
| MARSHALL WACE, LLP | $216 873 381 | 545 978 | 0,41% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $189 649 820 | 1 093 776 | 0,36% | Akcje |
| CITADEL ADVISORS LLC | $178 360 519 | 449 022 | 0,34% | Akcje |
| High Ground Investment Management LLP | $177 941 848 | 447 968 | 0,34% | Akcje |
| 1832 Asset Management L.P. | $176 401 430 | 444 090 | 0,33% | Akcje |
| BCV Asset Management Inc. | $173 695 656 | 445 719 | 0,33% | Akcje |
| Nuveen, LLC | $167 646 743 | 422 051 | 0,32% | Akcje |
| Holocene Advisors, LP | $165 040 541 | 415 489 | 0,31% | Akcje |
| DEUTSCHE BANK AG\ | $163 345 207 | 411 221 | 0,31% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| David A. Jones ×2 zgłoszenia | 12 listopada 2003 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 79 insiderów · 48 dyrektorzy generalni · 29 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 1 maja 2026 A | 63 938 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 21 lutego 2024 A | 110 130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 1 maja 2026 A | 39 637 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 31 grudnia 2024 J | 20 165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 22 lutego 2021 A | 24 342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 9 maja 2014 G | 14 916 | 0 | 0 | $0 |
| Aaron Martin | President, Medicare Advantage | 1 maja 2026 A | 25 237 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 1 maja 2026 A | 25 407 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 1 maja 2026 A | 22 088 | 1 | 0 | $150 012 |
| George Renaudin II | President, Insurance | 31 marca 2026 J | 16 075 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 24 lutego 2023 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 15 grudnia 2022 M | 3 983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 15 grudnia 2017 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 18 lutego 2014 A | 105 443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 31 marca 2017 J | 34 668 | 0 | 0 | $0 |
| Shantanu Nundy | Chief Medical Officer | 1 września 2026 A | 2 549 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 1 maja 2026 A | 17 176 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 1 maja 2026 A | 20 026 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 1 maja 2026 A | 27 405 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 24 lutego 2026 F | 7 484 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 24 lutego 2025 A | 16 717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 31 grudnia 2024 G | 7 111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 15 grudnia 2024 M | 14 015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 21 lutego 2024 A | 11 723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 24 lutego 2023 F | 3 687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 1 maja 2022 M | 4 294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 22 marca 2022 J | 5 723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 25 lutego 2022 F | 6 014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 16 marca 2021 G | 8 168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 18 grudnia 2019 M | 18 092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 15 grudnia 2019 M | 6 339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 25 lutego 2019 A | 9 774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 19 lutego 2019 M | 10 791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 15 grudnia 2018 M | 11 136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 15 grudnia 2018 M | 6 476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 17 marca 2017 M | 4 361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 18 lutego 2014 A | 1 101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 18 lutego 2014 A | 15 946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 24 czerwca 2013 M | 19 347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 24 grudnia 2012 G | 2 287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 28 kwietnia 2012 F | 11 946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 23 lutego 2012 A | 23 280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 4 lutego 2009 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 27 marca 2008 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 25 lutego 2008 F | 13 836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 31 grudnia 2007 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 23 lutego 2007 M | 57 548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 6 stycznia 2005 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | Dyrektor | 30 września 2026 A | 19 448 | 0 | 0 | $0 |
| Paul John Smith | Dyrektor | 1 sierpnia 2026 A | 544 | 0 | 0 | $0 |
| Robert Stuart Field | Dyrektor | 1 maja 2026 A | 852 | 0 | 0 | $0 |
| Jorge S. Mesquita | Dyrektor | 2 stycznia 2026 A | 4 127 | 0 | 0 | $0 |
| Frank A Damelio | Dyrektor | 2 stycznia 2026 A | 20 634 | 0 | 0 | $0 |
| Raquel C. Bono | Dyrektor | 31 grudnia 2025 A | 397 | 0 | 0 | $0 |
| Wayne A.I. Frederick | Dyrektor | 31 grudnia 2025 A | 440 | 0 | 0 | $0 |
| Marcy S Klevorn | Dyrektor | 31 grudnia 2025 A | 436 | 0 | 0 | $0 |
| John W Garratt | Dyrektor | 31 grudnia 2025 A | 1 685 | 0 | 0 | $0 |
| David T Feinberg | Dyrektor | 31 grudnia 2025 A | 1 207 | 0 | 0 | $0 |
| Karen Katz | Dyrektor | 31 grudnia 2025 A | 590 | 0 | 0 | $0 |
| Brad D Smith | Dyrektor | 31 grudnia 2024 A | 1 169 | 0 | 0 | $0 |
| William J. Mcdonald | Dyrektor | 2 stycznia 2024 A | 2 276 | 0 | 0 | $0 |
| JONES DAVID A JR/KY | Dyrektor | 28 lutego 2023 G | 32 440 | 0 | 0 | $0 |
| OBRIEN JAMES J /KY | Dyrektor | 3 stycznia 2023 A | 1 794 | 0 | 0 | $0 |
| Marissa T Peterson | Dyrektor | 3 stycznia 2022 A | 2 044 | 0 | 0 | $0 |
| Frank Bisignano | Dyrektor | 4 stycznia 2021 A | 2 727 | 0 | 0 | $0 |
| Webster Roy Dunbar | Dyrektor | 31 grudnia 2019 A | 2 880 | 0 | 0 | $0 |
| Karen B Desalvo | Dyrektor | 2 stycznia 2019 A | 634 | 0 | 0 | $0 |
| David Nash | Dyrektor | 2 stycznia 2019 A | 112 | 0 | 0 | $0 |
| William Mitchell | Dyrektor | 31 grudnia 2018 A | 688 | 0 | 0 | $0 |
| Michael B Mccallister | Dyrektor | 31 grudnia 2013 M | 113 885 | 0 | 0 | $0 |
| Ann W Reynolds | Dyrektor | 15 maja 2011 M | 39 727 | 0 | 0 | $0 |
| James O Robbins | Dyrektor | 3 stycznia 2007 A | · | 0 | 0 | $0 |
| HALL JOHN R /KY | Dyrektor | 3 stycznia 2006 A | 22 423 | 0 | 0 | $0 |
| JONES DAVID A SR/KY | Dyrektor | 5 kwietnia 2005 G | 4 777 524 | 0 | 0 | $0 |
| Michael E Gellert | Dyrektor | 3 stycznia 2005 A | 60 237 | 0 | 0 | $0 |
| Irwin Lerner | Dyrektor | 2 stycznia 2004 A | 30 637 | 0 | 0 | $0 |
| Frederick John Crawford | · | 1 sierpnia 2026 A | 544 | 0 | 0 | $0 |
| Gordon Smith | · | 31 grudnia 2025 A | 765 | 0 | 0 | $0 |
| James H Bloem | · | 7 listopada 2013 M | 30 326 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 143 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHF · iShares Trust | 4,63% | 151 582 SH | 11 września 2026 | Dziennie |
| FMTM · EA Series Trust | 3,07% | 21 303 NS | 31 lipca 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2,57% | 1 854 NS | 31 lipca 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,35% | 103 450 SH | 2 października 2026 | Dziennie |
| SRHQ · Elevation Series Trust | 2,31% | 13 473 NS | 31 lipca 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,75% | 225 NS | 31 lipca 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1,71% | 2 014 NS | 31 lipca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,57% | 35 951 SH | 2 października 2026 | Dziennie |
| NUMV · Nushares ETF Trust | 1,39% | 16 939 NS | 31 lipca 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,16% | 290 NS | 31 lipca 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,88% | 32 276 NS | 31 lipca 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,82% | 771 237 SH | 19 sierpnia 2026 | Dziennie |
| IYH · iShares Trust | 0,78% | 70 303 SH | 11 września 2026 | Dziennie |
| JOET · Virtus ETF Trust II | 0,74% | 4 940 NS | 31 lipca 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,74% | 4 248 NS | 31 lipca 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,71% | 181 374 SH | 2 października 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,70% | 360 880 SH | 19 sierpnia 2026 | Dziennie |
| PDP · Invesco Exchange-Traded Fund Trust | 0,70% | 27 208 SH | 2 października 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,63% | 57 108 NS | 31 lipca 2026 | N-PORT |
| IXJ · iShares Trust | 0,61% | 63 215 SH | 11 września 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,50% | 2 362 NS | 31 lipca 2026 | N-PORT |
| IWS · iShares Trust | 0,47% | 179 478 SH | 11 września 2026 | Dziennie |
| VO · VANGUARD INDEX FUNDS | 0,46% | 2 601 869 SH | 19 sierpnia 2026 | Dziennie |
| IMCV · iShares Trust | 0,40% | 11 586 SH | 11 września 2026 | Dziennie |
| MTUM · iShares Trust | 0,37% | 227 558 SH | 11 września 2026 | Dziennie |
| IWR · iShares Trust | 0,35% | 492 212 SH | 11 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,34% | 88 063 SH | 2 października 2026 | Dziennie |
| IMCB · iShares Trust | 0,34% | 14 123 SH | 11 września 2026 | Dziennie |
| VRP · Invesco Exchange-Traded Fund Trust … | 0,33% | 10 420 000 | 2 października 2026 | Dziennie |
| FFLC · FIDELITY COVINGTON TRUST | 0,32% | 10 722 NS | 31 lipca 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,32% | 8 116 SH | 2 października 2026 | Dziennie |
| IMCG · iShares Trust | 0,27% | 27 157 SH | 11 września 2026 | Dziennie |
| XOEF · iShares Trust | 0,27% | 151 SH | 11 września 2026 | Dziennie |
| VLUE · iShares Trust | 0,26% | 62 879 SH | 11 września 2026 | Dziennie |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,25% | 320 000 | 2 października 2026 | Dziennie |
| SIZE · iShares Trust | 0,24% | 2 599 SH | 11 września 2026 | Dziennie |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,23% | 8 027 000 | 2 października 2026 | Dziennie |
| ROUS · Lattice Strategies Trust | 0,23% | 4 462 NS | 31 lipca 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,22% | 9 983 000 | 2 października 2026 | Dziennie |
| EUSA · iShares, Inc. | 0,22% | 10 324 SH | 11 września 2026 | Dziennie |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 26 395 NS | 31 lipca 2026 | N-PORT |
| CATH · Global X Funds | 0,21% | 7 419 NS | 31 lipca 2026 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 0,20% | 479 438 SH | 19 sierpnia 2026 | Dziennie |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 487 833 SH | 2 października 2026 | Dziennie |
| EVUS · iShares Trust | 0,19% | 1 842 SH | 11 września 2026 | Dziennie |
| USXF · iShares Trust | 0,19% | 7 125 SH | 11 września 2026 | Dziennie |
| ESMV · iShares Trust | 0,19% | 37 SH | 11 września 2026 | Dziennie |
| SUSA · iShares Trust | 0,19% | 19 078 SH | 11 września 2026 | Dziennie |
| ACVF · ETF Opportunities Trust | 0,19% | 790 NS | 31 lipca 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,18% | 1 140 642 SH | 19 sierpnia 2026 | Dziennie |
| DFLV · Dimensional ETF Trust | 0,18% | 32 943 NS | 31 lipca 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 3 921 NS | 31 lipca 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,17% | 3 648 SH | 19 sierpnia 2026 | Dziennie |
| DFSU · Dimensional ETF Trust | 0,17% | 10 472 NS | 31 lipca 2026 | N-PORT |
| IVE · iShares Trust | 0,16% | 200 080 SH | 11 września 2026 | Dziennie |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,16% | 27 648 SH | 19 sierpnia 2026 | Dziennie |
| IUSV · iShares Trust | 0,15% | 104 740 SH | 11 września 2026 | Dziennie |
| VEGN · ETF Series Solutions | 0,15% | 709 NS | 31 lipca 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,14% | 60 086 NS | 31 lipca 2026 | N-PORT |
| SUSL · iShares Trust | 0,14% | 4 238 SH | 11 września 2026 | Dziennie |
| FYEE · Fidelity Greenwood Street Trust | 0,14% | 839 NS | 31 lipca 2026 | N-PORT |
| DSI · iShares Trust | 0,14% | 18 418 SH | 11 września 2026 | Dziennie |
| IQSU · New York Life Investments ETF Trust | 0,14% | 1 230 NS | 31 lipca 2026 | N-PORT |
| CHRI · Global X Funds | 0,13% | 29 NS | 31 lipca 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 72 504 SH | 19 sierpnia 2026 | Dziennie |
| IWD · iShares Trust | 0,13% | 267 199 SH | 11 września 2026 | Dziennie |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,12% | 3 809 000 | 2 października 2026 | Dziennie |
| NULV · Nushares ETF Trust | 0,11% | 6 797 NS | 31 lipca 2026 | N-PORT |
| ESGU · iShares Trust | 0,11% | 47 962 SH | 11 września 2026 | Dziennie |
| DGRO · iShares Trust | 0,10% | 111 232 SH | 11 września 2026 | Dziennie |
| EGLE · Global X Funds | 0,10% | 6 NS | 31 lipca 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,10% | 3 NS | 31 lipca 2026 | N-PORT |
| LQAI · Exchange Listed Funds Trust | 0,10% | 6 NS | 31 lipca 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 1 886 SH | 2 października 2026 | Dziennie |
| TOPC · iShares Trust | 0,09% | 72 SH | 11 września 2026 | Dziennie |
| ILCV · iShares Trust | 0,08% | 2 783 SH | 11 września 2026 | Dziennie |
| XVV · iShares Trust | 0,08% | 1 375 SH | 11 września 2026 | Dziennie |
| VV · VANGUARD INDEX FUNDS | 0,08% | 140 219 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,08% | 27 152 SH | 19 sierpnia 2026 | Dziennie |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,08% | 3 447 SH | 2 października 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,08% | 100 648 NS | 31 lipca 2026 | N-PORT |
| XTR · Global X Funds | 0,08% | 10 NS | 31 lipca 2026 | N-PORT |
| IVV · iShares Trust | 0,07% | 1 513 176 SH | 11 września 2026 | Dziennie |
| ILCB · iShares Trust | 0,07% | 2 328 SH | 11 września 2026 | Dziennie |
| XCLR · Global X Funds | 0,07% | 7 NS | 31 lipca 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,07% | 3 119 147 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,07% | 3 812 375 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,07% | 19 809 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,07% | 10 113 SH | 19 sierpnia 2026 | Dziennie |
| PBP · Invesco Exchange-Traded Fund Trust | 0,07% | 715 SH | 2 października 2026 | Dziennie |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,07% | 20 848 SH | 2 października 2026 | Dziennie |
| IYY · iShares Trust | 0,07% | 5 172 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,07% | 82 919 SH | 11 września 2026 | Dziennie |
| XYLD · Global X Funds | 0,07% | 6 091 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,07% | 6 112 NS | 31 lipca 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 16 615 NS | 31 lipca 2026 | N-PORT |
| USCL · iShares Trust | 0,07% | 4 768 SH | 11 września 2026 | Dziennie |
| VOTE · TCW ETF Trust | 0,07% | 2 035 NS | 31 lipca 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,07% | 10 127 NS | 31 lipca 2026 | N-PORT |
| XRMI · Global X Funds | 0,07% | 92 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,07% | 33 101 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,07% | 156 223 SH | 11 września 2026 | Dziennie |
| LRGF · iShares Trust | 0,06% | 5 842 SH | 11 września 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,06% | 959 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,06% | 36 333 NS | 31 lipca 2026 | N-PORT |
| XYLG · Global X Funds | 0,06% | 111 NS | 31 lipca 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,06% | 453 NS | 31 lipca 2026 | N-PORT |
| ILCG · iShares Trust | 0,06% | 4 804 SH | 11 września 2026 | Dziennie |
| QDPL · Pacer Funds Trust | 0,06% | 2 883 NS | 31 lipca 2026 | N-PORT |
| TOV · EA Series Trust | 0,06% | 454 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,06% | 3 564 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,06% | 20 053 NS | 31 lipca 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,06% | 95 SH | 2 października 2026 | Dziennie |
| VOXP · Advisors Series Trust | 0,06% | 9 NS | 31 lipca 2026 | N-PORT |
| TOK · iShares Trust | 0,06% | 333 SH | 11 września 2026 | Dziennie |
| HCMT · Direxion Shares ETF Trust | 0,05% | 835 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,05% | 4 948 NS | 31 lipca 2026 | N-PORT |
| URTH · iShares, Inc. | 0,05% | 10 772 SH | 11 września 2026 | Dziennie |
| SPXL · Direxion Shares ETF Trust | 0,05% | 9 382 NS | 31 lipca 2026 | N-PORT |
| ACWI · iShares Trust | 0,05% | 38 539 SH | 11 września 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,04% | 196 805 SH | 19 sierpnia 2026 | Dziennie |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,04% | 4 718 SH | 2 października 2026 | Dziennie |
| NEAR · iShares U.S. ETF Trust | 0,03% | 1 504 000 SH | 11 września 2026 | Dziennie |
| GLOF · iShares Trust | 0,02% | 106 SH | 11 września 2026 | Dziennie |
| DYNF · BlackRock ETF Trust | 0,01% | 14 919 SH | 11 września 2026 | Dziennie |
| CRBN · iShares Trust | 0,01% | 383 SH | 11 września 2026 | Dziennie |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 4 397 881 SH | 19 sierpnia 2026 | Dziennie |
| VPL · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 401 850 SH | 19 sierpnia 2026 | Dziennie |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 932 492 SH | 19 sierpnia 2026 | Dziennie |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 2 391 019 SH | 19 sierpnia 2026 | Dziennie |
| VSGX · VANGUARD WORLD FUND | 0,00% | 54 062 SH | 19 sierpnia 2026 | Dziennie |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| VCEB · VANGUARD WORLD FUND | · | · | 30 lipca 2026 | Dziennie |
HUM Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
23 analityków · 2026-09-30Średnia cel $423.74 +9,1%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.